Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
1998

Prognostic Value of Cathepsin D in Breast Cancer

Sample size: 103 publication Evidence: moderate

Author Information

Author(s): A Losch, C Tempfer, P Kohlberger, EA Joura, M Denk, B Zajic, G Breitenecker, C Kainz

Primary Institution: University of Vienna

Hypothesis

What is the prognostic value of cathepsin D expression in breast cancer?

Conclusion

Cathepsin D expression in the epithelial component of breast cancer is associated with poor overall survival, but it does not provide additional prognostic information when considered with established factors.

Supporting Evidence

  • Positive epithelial cathepsin D expression was found in 31.1% of patients.
  • Cathepsin D expression was associated with stage and nuclear grade.
  • Stromal cathepsin D expression showed no significant association with survival.
  • Multivariate analysis revealed cathepsin D expression was not an independent predictor of outcome.
  • Cathepsin D expression had significant prognostic value for overall survival and recurrence-free interval.

Takeaway

This study looked at a protein called cathepsin D in breast cancer and found that when it's present in the cancer cells, it can mean the patient might not do as well, but it doesn't help predict outcomes beyond what doctors already know.

Methodology

The study analyzed 103 paraffin-embedded tumor specimens from women with invasive ductal carcinoma, assessing cathepsin D expression using immunohistochemistry.

Potential Biases

There may be interobserver variability in the assessment of staining.

Limitations

The study's sample size was limited, and the analysis did not account for pre- and postmenopausal status or lymph node-positive and -negative patients in subgroup analysis.

Participant Demographics

The mean age of participants was 54 years, with a range from 23 to 81 years; 42 were premenopausal and 61 were postmenopausal.

Statistical Information

P-Value

0.003 and 0.01 for overall survival

Confidence Interval

1.1 (0.4-3.0) for CD+/TU

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication